RG-101: Additional Phase I data

Top-line data from 14 patients with HCV infection in the second cohort of Part 4 of a 4-part, placebo-controlled, Dutch Phase I trial showed that a single subcutaneous

Read the full 280 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE